Untitled

Literature References

• Scully et al., Nat Rev Mol Cell Biol, 2019

• Marco Gatti BIO257 DNA Metabolism and Cancer DSBs Repair Pathways, Genomic Instability and Cancer, October 13, 2025

Outline of Key Topics

• DNA Damage Response (DDR) and DSBs

• Significance: Genomic instability and therapy implications

• Sources of DSBs

• DSBs Repair Pathways: Homologous Recombination (HR) and Non-Homologous End Joining (NHEJ)

• Key Proteins Involved: BRCA1 and 53BP1

DNA Damage Response (DDR)

• DDR is crucial for maintaining genomic stability.

• Double-Strand Breaks (DSBs): Considered highly deleterious types of DNA damage as they can disrupt gene structure and function, leading to rearrangements, translocations, and potential tumorigenesis.

• Mediator proteins coordinate and organize the DDR, acting as bridges between sensors and effectors.

Key Mediators

• Mediators: Kinase proteins such as γH2AX that respond to DSBs and facilitate the subsequent repair processes.

• BRCA1: Functions as a mediator for homologous recombination (HR).

Slide 3 – The DNA Damage Response (DDR): Overview

Key Concepts and Explanations:

• The DNA Damage Response (DDR) is a complex cellular defense network that detects, signals, and repairs DNA lesions to maintain genomic integrity.

• Types of DNA damage:

  • SSBs (Single-Strand Breaks)

  • DSBs (Double-Strand Breaks)

  • 8-oxoG (oxidized bases)

  • abasic sites

  • thymine dimers (caused by UV light)

  • crosslinks (caused by chemicals or radiation)

• DDR Process:

  1. Sensors detect the damage.

  2. Transducers amplify the signal via kinase cascades.

  3. Effectors coordinate cellular responses:

     • Checkpoint arrest → stops cell cycle to allow repair.

     • DNA repair → fixes the lesion.

     • Programmed cell death (apoptosis) → removes irreparable cells.

Explanation of Visuals:

• The schematic shows DNA with various lesions (red marks) and arrows leading to checkpoint arrest, DNA repair, or cell death.

• The pathway from “Sensors → Transducers → Effectors” illustrates the DDR signaling hierarchy.

Glossary:

• DSB (Double-Strand Break): Both DNA strands are severed — highly lethal if unrepaired.

• Checkpoint arrest: Temporary halting of cell cycle to enable repair.

• Apoptosis: Programmed self-destruction of severely damaged cells.

Key Takeaway:

Slide 4 – The DNA Damage Response (DDR): Key Players

Key Concepts and Explanations:

• The slide expands on DDR organization and identifies specific molecular players involved in damage recognition and signaling.

• Core DDR components:

  • Sensors: Detect DNA breaks (e.g., γH2AX).

  • Mediators: Recruit repair complexes and amplify signals (e.g., BRCA1, 53BP1).

  • Effectors: Execute downstream responses (e.g., p53).

Mechanistic Overview:

1. γH2AX (phosphorylated histone H2AX) marks DNA damage sites and recruits repair factors.

2. BRCA1 mediates homologous recombination repair.

3. 53BP1 promotes non-homologous end joining (NHEJ).

4. p53, a key effector, determines cellular fate — repair vs. apoptosis.

Explanation of Visuals:

• Left diagram: interplay between DNA damage checkpoint factors and DNA repair factors.

  • HR (Homologous Recombination) and NHEJ are the main DSB repair pathways.

  • DDR involves transcription machinery, chromatin modulators, and histone modifiers.

• Right side: microscopic images show DDR proteins localized at damage sites.

  • γH2AX (sensor), BRCA1 / 53BP1 (mediators), p53 (effector).

Glossary:

• γH2AX: Histone variant phosphorylated near DSBs — hallmark of DNA damage.

• BRCA1: Tumor suppressor involved in error-free repair (HR).

• 53BP1: Promotes NHEJ, an alternative error-prone DSB repair.

• p53: Transcription factor triggering DNA repair or apoptosis.

Key Takeaway:

Slide 5 – The DNA Damage Response (DDR): Pathway Integration

Key Concepts and Explanations:

• This slide emphasizes that the DDR is not a single pathway but an integrated network connecting DNA repair to cell-cycle regulation and cancer prevention.

• Distinct responses to different types of DNA breaks:

  • SSBs: repaired by Base Excision Repair (BER) or Single-Strand Break Repair (SSBR).

  • DSBs: repaired by Homologous Recombination (HR) or Non-Homologous End Joining (NHEJ).

• Chromatin remodeling and histone modifications regulate DDR protein access to DNA.

Mechanistic Insight:

• DDR signaling activates cell-cycle checkpoints (ATM/ATR kinases) to delay division.

• If repair fails, p53-dependent apoptosis eliminates damaged cells.

• Genomic instability arises when these safeguards fail — contributing to tumorigenesis.

Explanation of Visuals:

• Left: schematic overview of DDR including SSBs, DSBs, histones, and chromatin context.

• Right: cell-cycle wheel showing checkpoints (G1/S, intra-S, G2/M) under DDR control.

• Red text highlights the link between DDR malfunction and cancer.

Glossary:

• ATM/ATR: Kinases activating checkpoint signaling upon DNA damage.

• HR (Homologous Recombination): High-fidelity DSB repair using a sister chromatid as a template.

• NHEJ (Non-Homologous End Joining): Quick, error-prone DSB repair joining DNA ends directly.

Key Takeaway:

Slide 6 – Significance: Genome Instability Drives Tumorigenesis

Key Concepts and Explanations:

• Genome instability is a central hallmark of cancer — it fuels tumor evolution by increasing mutation rates.

• When DNA damage escapes repair, cells accumulate mutations and undergo malignant transformation.

Mechanistic Overview:

1. Healthy cell: Maintains intact DNA and normal DDR function.

2. Premalignant cell: Acquires mutations in key genes (e.g., repair enzymes, oncogenes).

3. Cancer cell: Accumulates additional mutations → genomic instability → tumor heterogeneity.

4. Inheritance of instability: Damaged DNA is passed on to daughter cells, perpetuating errors.

Explanation of Visuals:

• Sequential diagram shows progression from a healthy to a cancer cell:

  • DNA damage → driver mutation → accumulation of instability → malignant transformation.

• Red text highlights that the process becomes irreversible once instability is transmitted through cell division.

Glossary:

• Genome instability: Continuous accumulation of DNA mutations and chromosomal errors.

• Tumorigenesis: Formation and development of cancer.

• Malignant transformation: Conversion of a normal cell into a cancerous one.

Key Takeaway:

Slide 7 – Significance: Double-Strand Breaks (DSBs) Can Kill a Cell

Key Concepts and Explanations:

• DSBs (Double-Strand Breaks) are the most lethal type of DNA damage.

• Even a single unrepaired DSB can be sufficient to kill a cell, depending on:

  1. Where the break occurs:

     • If an essential gene is disrupted, the cell cannot survive.

  2. How the cell responds:

     • Activation of apoptosis (programmed cell death) if damage is detected but cannot be repaired.

• This concept forms the molecular basis of radiotherapy and certain chemotherapies, which deliberately induce DSBs to destroy cancer cells.

Explanation of Visuals:

• Two medical imaging panels (left vs. right) show tumor regression after radiation or chemotherapy treatment, which induce extensive DSBs.

• A smiling icon and highlighted text emphasize that inducing DSBs is an intentional therapeutic mechanism.

Glossary:

• Double-strand break (DSB): DNA damage where both strands are severed.

• Apoptosis: Programmed cell death removing severely damaged cells.

• Radiotherapy: Cancer treatment using ionizing radiation to induce DSBs.

Key Takeaway:

Slide 8 – Significance: Misrepair of DSBs Leads to Genomic Instability and Cancer

Key Concepts and Explanations:

• While some DSBs cause cell death, incorrectly repaired breaks lead to genomic rearrangements that promote cancer development.

• Consequences of DSB misrepair:

  1. Chromosomal translocations: Exchange of DNA between non-homologous chromosomes → abnormal gene fusions.

  2. Loss or duplication of chromosomal regions: Alters gene dosage.

  3. Inactivation of tumor suppressor genes (e.g., p53).

  4. Activation of proto-oncogenes → uncontrolled growth.

Examples of Oncogenic Translocations:

• t(9;22) Philadelphia chromosome: Creates the BCR–ABL fusion gene → causes chronic myeloid leukemia (CML).

• t(8;14) in Burkitt’s lymphoma: Fuses MYC (oncogene) to immunoglobulin heavy-chain promoter → drives overexpression and cell proliferation.

Explanation of Visuals:

• The diagram shows how misrepaired DSBs result in chromosomal translocations, where fragments of two chromosomes (e.g., 9 and 22) exchange material.

• Arrows trace the fusion leading to the BCR–ABL oncogenic protein.

Glossary:

• Chromosomal translocation: Rearrangement joining DNA from different chromosomes.

• Proto-oncogene: Normal gene that can become cancer-promoting when overactivated.

• Tumor suppressor gene: Gene that normally prevents uncontrolled cell growth.

Key Takeaway:

Slide 9 – Genomic Instability: A Hallmark of Cancer Cells (1)

Key Concepts and Explanations:

• Genomic instability is one of the core hallmarks of cancer — it describes the accumulation of structural and numerical chromosomal abnormalities.

• Cancer cells display chaotic karyotypes with:

  • Chromosomal translocations

  • Deletions

  • Duplications

  • Aneuploidy (abnormal chromosome number)

Explanation of Visuals:

• Left panel (normal cell): Shows a normal karyotype with 46 organized chromosomes.

• Right panel (tumor cell): Shows a breast cancer cell karyotype with extensive rearrangements, gains, and losses of chromosomes.

• The images visually demonstrate how cancer genomes become disorganized through repeated DNA damage and misrepair.

Glossary:

• Karyotype: The complete set of chromosomes in a cell, visualized by microscopy.

• Aneuploidy: Presence of abnormal chromosome numbers (e.g., 45 or 47 instead of 46).

• Structural aberration: Chromosomal rearrangement (translocation, deletion, inversion).

Key Takeaway:

Slide 10 – Genomic Instability: A Hallmark of Cancer Cells (2)

Key Concepts and Explanations:

• Expands on the previous slide with multiple cancer cell examples (MCF7, SW480, U2OS), each showing distinct chromosomal rearrangements.

• Different cancer types display unique instability patterns, but all share the common feature of structural chaos caused by DNA damage.

Mechanistic Insight:

• Structural chromosomal instabilities arise when DSBs are:

  • Unrepaired → chromosome fragments lost or degraded.

  • Misrepaired → fragments rejoined incorrectly, forming translocations or fusions.

• Over time, this creates a “mutator phenotype” — cells with increased mutation rates, fueling cancer evolution and drug resistance.

Explanation of Visuals:

• The karyotype panels from various tumor lines (MCF7 – breast cancer, SW480 – colorectal cancer, U2OS – osteosarcoma) show:

  • Fragmented, rearranged chromosomes with multiple colors (indicative of translocations).

• The yellow text box highlights the main message:

  “Structural chromosomal instabilities (e.g., translocations) arise through mis- or unrepaired DNA double-strand breaks (DSBs).”

Glossary:

• Translocation: Exchange of chromosome segments between non-homologous chromosomes.

• Mutator phenotype: Cellular state with elevated mutation frequency.

• U2OS / MCF7 / SW480: Commonly used human cancer cell lines representing different tissues.

Key Takeaway:

Slide 11 – Significance: Inherited Defects in DSB Repair Can Cause Cancer

Key Concepts and Explanations:

• Inherited mutations in DSB repair genes dramatically increase cancer risk.

• Two major genes involved are BRCA1 and BRCA2, both functioning as tumor suppressors essential for Homologous Recombination (HR) repair of double-strand breaks (DSBs).

Mechanism:

1. Normal Function:

   • BRCA1 and BRCA2 coordinate HR, an error-free DSB repair pathway active during the S and G2 cell-cycle phases.

   • They stabilize replication forks and recruit RAD51 to repair breaks precisely.

2. When Mutated:

   • DSBs are repaired inaccurately or not at all.

   • Cells accumulate chromosomal abnormalities and mutations, promoting tumorigenesis.

3. Cancer Susceptibility:

   • BRCA1/2 mutations are heritable (germline) and significantly raise breast and ovarian cancer risk.

Explanation of Visuals:

• Graph: Compares the proportion of breast cancer cases in the general population vs. BRCA1 and BRCA2 carriers.

  • ~11% lifetime risk in the general population.

  • ~65% lifetime risk in BRCA1 mutation carriers.

  • ~45% lifetime risk in BRCA2 mutation carriers.

• Text highlight: “1 in 9 women will develop breast cancer,” but “2 in 3 women carrying a BRCA1 mutation will develop breast cancer.”

Glossary:

• Tumor suppressor gene: A gene that prevents uncontrolled cell growth; loss of function promotes cancer.

• BRCA1/2: Genes encoding proteins that facilitate accurate DSB repair through HR.

• Germline mutation: Inherited mutation present in all body cells.

Key Takeaway:

Slide 12 – Significance: Synthetic Lethal Relationship in DDR Genes

Key Concepts and Explanations:

• Synthetic lethality occurs when two gene defects together are lethal to a cell, but each defect alone is survivable.

• In cancer therapy, this concept is exploited by targeting backup repair pathways in cells that already have one defective repair gene (e.g., BRCA1/2).

• Example: PARP inhibitors selectively kill BRCA-deficient cancer cells.

Mechanism:

1. Normal cells:

   • Both BRCA (HR repair) and PARP (SSB repair) function → cell survives.

2. BRCA-deficient cells:

   • HR pathway is inactive, but PARP-mediated repair still allows survival.

3. PARP inhibition (with BRCA mutation):

   • Both DSB and SSB repair are blocked.

   • Accumulated SSBs collapse into DSBs during replication → cell death.

   • Cancer-specific lethality achieved while sparing normal cells.

Explanation of Visuals:

• Table/diagram shows the four combinations:

  • Only double mutation (BRCA⁻/⁻ + PARP⁻/⁻) leads to cell death.

• Right image shows Olaparib (Lynparza), a clinical PARP inhibitor approved for BRCA-mutant cancers (breast, ovarian, prostate, pancreatic).

Glossary:

• PARP (Poly ADP-ribose polymerase): Enzyme repairing single-strand breaks.

• Synthetic lethality: Condition where combined defects in two genes are lethal, but each defect alone is not.

• Olaparib: PARP inhibitor drug exploiting BRCA deficiency.

Key Takeaway:

Slide 13 – Sources of DSBs: Exogenous Agents

Key Concepts and Explanations:

• DSBs can arise from external (exogenous) sources such as ionizing radiation (IR).

• Ionizing radiation includes:

  • Radioactive decay (γ-rays)

  • Cosmic radiation

  • Medical X-rays (diagnostic or therapeutic)

Key Facts:

• Ionizing radiation creates DSBs directly (by breaking DNA bonds) and indirectly (via reactive oxygen species, ROS).

• 1 Gray (Gy) of ionizing radiation induces 20–40 DSBs per cell.

Typical Exposure Levels and Estimated DSBs per Cell:

Explanation of Visuals:

• The radiation hazard symbol and table summarize the relative DSB-inducing potential of medical and environmental exposures.

• Text emphasizes that radiotherapy intentionally causes DSBs to kill tumor cells.

Glossary:

• Gray (Gy): SI unit of absorbed radiation dose (1 Gy = 1 Joule/kg tissue).

• Ionizing radiation: High-energy radiation that removes electrons from atoms, damaging DNA.

• Reactive oxygen species (ROS): Highly reactive molecules formed during radiation that indirectly damage DNA.

Key Takeaway:

Slide 14 – Sources of DSBs: Direct and Indirect DNA Damage by IR

Key Concepts and Explanations:

• Ionizing radiation (IR) generates DSBs through two mechanisms:

  1. Direct action: Radiation directly ionizes DNA atoms, breaking the sugar-phosphate backbone.

  2. Indirect action: Radiation ionizes water molecules, producing reactive oxygen species (ROS) that chemically attack DNA.

Mechanistic Details:

• Direct action:

  • Occurs when high-energy particles hit DNA directly.

  • Causes immediate strand breaks or base damage.

• Indirect action:

  • IR splits water (H₂O) into radicals: hydroxyl radicals (•OH), hydrogen peroxide (H₂O₂), and superoxide (O₂•⁻).

  • These ROS diffuse and react with DNA, causing oxidation, base modification, and strand breaks.

  • Indirect action accounts for about two-thirds of all IR-induced DNA damage.

Explanation of Visuals:

• Left image: Direct interaction shows radiation hitting DNA directly.

• Right image: Radiolysis of water creates ROS, which attack DNA bases and the sugar backbone.

• Red text “Reactive oxygen species (ROS)” highlights the secondary chemical damage pathway.

Glossary:

• ROS (Reactive Oxygen Species): Chemically reactive molecules causing oxidative DNA damage.

• Radiolysis: Splitting of water molecules by radiation energy.

• Base oxidation: Chemical alteration of DNA bases, often leading to mutations.

Key Takeaway:

Slide 15 – Sources of DSBs: Exogenous Agents (Chemicals – Topoisomerase Inhibitors)

Key Concepts and Explanations:

• DNA topoisomerases are enzymes that resolve DNA supercoiling and tangles by transiently cutting and rejoining DNA strands.

• Certain chemicals (used as chemotherapy drugs) inhibit these enzymes, leading to persistent DNA breaks.

Mechanistic Overview:

• Type I Topoisomerases (TOP1):

  • Introduce single-strand breaks (SSBs) to relax DNA supercoils.

  • Inhibitors of TOP1 (e.g., Camptothecin, CPT) trap the enzyme-DNA complex, converting transient SSBs into DSBs during replication.

  • These DSBs mainly occur in S-phase (replication-dependent).

• Type II Topoisomerases (TOP2):

  • Cut both DNA strands to manage knots and tangles.

  • Inhibitors (e.g., Etoposide) trap TOP2-DNA complexes, generating DSBs throughout the cell cycle, even in non-dividing cells.

Explanation of Visuals:

• Diagram compares TOP1 and TOP2 actions:

  • Both enzymes transiently cut DNA and then re-ligate it.

  • Inhibitors prevent the re-ligation step, leaving the DNA “stuck” in a broken state.

Glossary:

• Topoisomerase: Enzyme that cuts and rejoins DNA to relieve torsional strain.

• Camptothecin (CPT): Natural alkaloid TOP1 inhibitor.

• Etoposide: Chemotherapy drug inhibiting TOP2, leading to DSB accumulation.

Key Takeaway:

Slide 16 – DNA Topoisomerase Inhibitors Block the DNA Religation Step

Key Concepts and Explanations:

• This slide details how topoisomerase inhibitors induce DNA damage by interfering with the re-ligation phase of the enzyme’s catalytic cycle.

• Normally:

  1. TOP1 or TOP2 binds DNA.

  2. The enzyme cleaves one (TOP1) or both (TOP2) strands, forming a transient cleavage complex.

  3. After relieving torsional stress, the enzyme rejoins the cut strands and releases DNA.

• Inhibitors (like CPT or etoposide) freeze the cleavage complex, preventing DNA rejoining and trapping the enzyme on the DNA.

Mechanistic Consequences:

• Replication forks or transcription machinery collide with these trapped complexes, converting transient nicks into double-strand breaks (DSBs).

• These collisions trigger replication stress, DNA damage signaling, and potentially apoptosis.

Explanation of Visuals:

• Multiple schematic steps (C–H) show:

  • TOP1 and TOP2 binding and cleaving DNA.

  • Inhibitors blocking religation.

  • Collision of replication machinery leading to strand breaks.

  • Accumulation of DSBs and apoptosis.

Glossary:

• Cleavage complex: Temporary intermediate where the enzyme is covalently attached to cleaved DNA.

• Replication fork: The moving complex that replicates DNA strands.

• Apoptosis: Programmed cell death triggered by excessive DNA damage.

Key Takeaway:

Slide 17 – Camptothecin Generates Replication-Induced DSBs

Key Concepts and Explanations:

• Camptothecin (CPT), a natural TOP1 inhibitor, specifically induces replication-associated DSBs.

• Mechanism of action:

  1. CPT stabilizes the TOP1–DNA cleavage complex, preventing re-ligation.

  2. When a replication fork collides with this stalled complex, the fork structure collapses.

  3. This collision produces a replication-associated double-strand break (DSB), also known as a replication run-off event.

Mechanistic Insight:

• The DSB arises on the leading strand of the replication fork, where the polymerase encounters the trapped TOP1-DNA intermediate.

• Such breaks trigger activation of DNA damage signaling pathways (ATR/CHK1) and can lead to cell cycle arrest or apoptosis if not repaired.

Explanation of Visuals:

• The figure illustrates:

  • A replication fork moving along DNA.

  • A trapped TOP1 complex (TOP1cc) blocking the fork.

  • Resulting replication-induced DSB forming after collision.

• Arrows indicate the direction of replication and break formation.

Glossary:

• TOP1cc: Covalent topoisomerase I–DNA cleavage complex stabilized by CPT.

• Replication run-off: Replication fork collapse caused by blockage or DNA lesions.

• ATR/CHK1 pathway: DNA damage checkpoint signaling activated by replication stress.

Key Takeaway:

Slide 18 – TOP1 Inhibitors and Cancer Chemotherapy

Key Concepts and Explanations:

• TOP1 inhibitors (e.g., camptothecin and its derivatives) are widely used in cancer chemotherapy due to their ability to selectively kill rapidly dividing cells.

• Mechanism of cytotoxicity:

  • Inhibiting TOP1 leads to persistent DNA cleavage complexes.

  • These cause replication fork stalling, transcriptional disruption, and chromosomal fragmentation.

  • The resulting DSBs trigger apoptosis in cancer cells.

Clinical Insights:

• Camptothecin (CPT):

  • Originally derived from the Chinese tree Camptotheca acuminata.

  • Early use was limited due to toxicity and poor solubility.

  • Now replaced by safer derivatives with improved pharmacokinetics.

• Modern derivatives:

  • Topotecan and Irinotecan are currently used clinically.

  • Indications: colorectal, ovarian, and lung cancers.

  • Both are prodrugs that stabilize TOP1–DNA complexes like CPT but with fewer side effects.

Explanation of Visuals:

• Text summary describing the clinical transition from CPT to its derivatives.

• Emphasized points in orange highlight the replacement of CPT by safer alternatives.

Glossary:

• Replication stress: Slowing or stalling of DNA replication due to DNA damage.

• Irinotecan / Topotecan: Camptothecin analogues used in modern cancer therapy.

• Prodrug: Inactive compound metabolized into an active drug inside the body.

Key Takeaway:

Slide 19 – Sources of DSBs: Exogenous Agents (DNA Crosslinking Agents)

Key Concepts and Explanations:

• DNA crosslinking agents are chemicals that create covalent links between DNA strands, physically preventing strand separation needed for replication and transcription.

• These agents induce interstrand crosslinks (ICLs) (between complementary strands) or intrastrand crosslinks (within the same strand).

Mechanism:

1. Crosslinks block DNA unwinding, stalling both replication and transcription.

2. This stalling eventually leads to replication fork collapse and formation of double-strand breaks (DSBs).

3. The cell relies on specialized pathways (e.g., the Fanconi Anemia (FA) pathway) to remove crosslinks and restore replication integrity.

Examples of DNA Crosslinking Agents:

• Mitomycin C

• Cyclophosphamide

• Cisplatin (widely used in chemotherapy)

Explanation of Visuals:

• The schematic shows transcription and replication blocked by a crosslinked region on the DNA, symbolizing the physical barrier preventing strand separation.

• The text highlights that DSBs are introduced as repair intermediates during the resolution of crosslinks by homologous recombination (HR).

Glossary:

• Interstrand Crosslink (ICL): Covalent bond connecting the two DNA strands, blocking their separation.

• Fanconi Anemia Pathway: DNA repair process that resolves ICLs through DSB intermediates.

• Cisplatin: Platinum-based chemotherapy drug that crosslinks DNA and kills cancer cells.

Key Takeaway:

Slide 20 – Sources of DSBs: Endogenous Causes

Key Concepts and Explanations:

• DSBs can also arise spontaneously within cells due to metabolic and physiological processes.

• On average, a human cell experiences ~10 DSBs per day under normal conditions.

Types of Endogenous DSB Induction:

1. Spontaneous (Accidental) Causes:

   • Reactive Oxygen Species (ROS):

     • Generated during mitochondrial metabolism and oxidative stress.

     • Cause base oxidation and strand cleavage, producing SSBs and DSBs.

   • Replication fork collapse:

     • Occurs when replication encounters obstacles such as DNA lesions or tightly bound proteins.

     • A major source of DSBs in dividing cells.

2. Physiological (Programmed) Causes:

   • Meiosis:

     • During gamete formation, intentional DSBs are introduced to initiate genetic recombination, increasing diversity.

   • V(D)J recombination:

     • In immune cells, DSBs are deliberately created to rearrange gene segments encoding antibodies and T-cell receptors, enabling immune diversity.

Explanation of Visuals:

• Text with yellow-highlighted boxes emphasizes “Generating Diversity” as the biological purpose of controlled DSB formation in meiosis and immune maturation.

Glossary:

• ROS (Reactive Oxygen Species): Molecules that oxidize DNA bases, leading to strand breaks.

• Replication fork collapse: Failure of replication progression due to DNA damage.

• V(D)J recombination: Rearrangement of gene segments in immune cells for antibody and TCR diversity.

Key Takeaway:

Slide 21 – Sources of DSBs: Experimental Introduction of Site-Specific Breaks

Key Concepts and Explanations:

• Scientists can artificially introduce DSBs at defined sites in DNA for experimental or therapeutic purposes.

• This enables controlled DNA repair studies or precise genome editing.

Mechanistic Approaches:

1. Expression of Restriction Endonucleases:

   • Enzymes such as I-SceI cut DNA at unique recognition sites to trigger site-specific DSBs.

   • Commonly used in assays to study DNA repair mechanisms (HR, NHEJ).

2. CRISPR/Cas9 System:

   • RNA-guided Cas9 nuclease introduces a DSB at a targeted genomic location.

   • The cell then repairs this break via:

     • NHEJ (Non-Homologous End Joining): Often results in small insertions or deletions (knockouts).

     • HR (Homologous Recombination): Allows precise DNA sequence insertion or correction (knock-in).

Explanation of Visuals:

• Diagram of CRISPR/Cas9 mechanism:

  • Cas9 enzyme guided by an RNA (sgRNA) binds to a complementary DNA target.

  • Creates a DSB at a specific site.

  • The break is repaired by cellular repair machinery.

• Arrows indicate NHEJ and HR outcomes.

Glossary:

• I-SceI: Restriction enzyme recognizing an 18-bp unique sequence, used in repair assays.

• CRISPR/Cas9: Genome editing tool derived from bacterial immune systems.

• sgRNA: Single-guide RNA directing Cas9 to its DNA target.

Key Takeaway:

Slide 22 – Major and Backup Pathways of DSB Repair

Key Concepts and Explanations:

• Cells use two main pathways to repair DSBs:

  1. Homologous Recombination (HR):

     • Accurate repair using a homologous DNA template (sister chromatid).

     • Predominantly active during S and G2 phases.

  2. Non-Homologous End Joining (NHEJ):

     • Fast but error-prone mechanism that directly rejoins broken DNA ends.

     • Active throughout the cell cycle, especially in G1 phase.

Backup or Alternative Pathways:

• MMEJ (Microhomology-Mediated End Joining): Uses small homologous sequences (2–25 bp) to rejoin DNA; often leads to deletions.

• SSA (Single-Strand Annealing): Repairs DSBs between repeated sequences, causing deletions between repeats.

• HR subpathways (SDSA, DSBR): Different mechanisms for strand invasion and resolution of recombination intermediates.

Explanation of Visuals:

• Central diagram highlights the decision point in DSB repair — whether the cell engages HR or NHEJ based on:

  • Cell cycle phase

  • DNA end processing

  • Protein availability (e.g., 53BP1 promotes NHEJ; BRCA1 promotes HR)

• Lower panels illustrate subpathways (SSA, SDSA, NHEJ) and their outcomes (accurate vs. mutagenic repair).

Glossary:

• HR (Homologous Recombination): Template-based, error-free DSB repair.

• NHEJ (Non-Homologous End Joining): Template-independent, error-prone repair.

• MMEJ / SSA: Backup error-prone repair routes relying on small homologies.

Key Takeaway:

Slide 23 – Cells Have Two Main Sensors for DSBs

Key Concepts and Explanations:

• The detection of DNA double-strand breaks (DSBs) is the first critical step in DNA damage response (DDR).

• Cells use two major DSB sensors, depending on which repair pathway (HR or NHEJ) is activated:

1. MRN Complex (involved in HR and damage signaling)

• Composition:

  • Mre11 – catalytic subunit with 3′–5′ exonuclease and endonuclease activity.

  • Rad50 – ATPase component that holds DNA ends together via long coiled coils.

  • Nbs1 – regulatory subunit linking MRN to signaling kinases (ATM).

• Functions:

  • Detects DSBs and bridges broken DNA ends.

  • Recruits and activates ATM kinase, initiating the DDR cascade.

  • Participates in DNA end resection, preparing for homologous recombination (HR).

2. Ku70–Ku80 Heterodimer (specific for NHEJ)

• Functions:

  • Directly binds DNA ends with high affinity and protects them from degradation.

  • Recruits other NHEJ repair proteins (e.g., DNA-PKcs, XRCC4, Ligase IV).

  • Stabilizes DSBs before ligation.

Explanation of Visuals:

• Diagram of MRN complex binding DNA ends.

• Structural model of Ku70–Ku80 heterodimer showing how it encircles DNA to anchor NHEJ machinery.

Glossary:

• ATM: Kinase activated by MRN to initiate checkpoint signaling.

• DNA-PKcs: Kinase recruited by Ku complex for NHEJ.

• Resection: Controlled digestion of DNA ends for HR initiation.

Key Takeaway:

Slide 24 – Ku Complex Promotes Non-Homologous End Joining (NHEJ)

Key Concepts and Explanations:

• The Ku70–Ku80 heterodimer acts as the core scaffold for NHEJ (Non-Homologous End Joining), recruiting and organizing repair enzymes at DSB sites.

Mechanistic Steps of NHEJ:

1. Recognition:

   • Ku70/Ku80 binds the DNA ends immediately after the break.

2. Recruitment:

   • DNA-PKcs (DNA-dependent protein kinase catalytic subunit) is recruited, forming the active DNA-PK holoenzyme.

3. Processing:

   • Damaged or mismatched DNA ends are processed by Artemis nucleases (Artemis)and makes a very small resection there and polymerases (e.g., Pol μ, Pol λ) to make them compatible for ligation.

4. Ligation:

   • The XRCC4–XLF–Ligase IV complex seals the break, restoring DNA integrity.

Explanation of Visuals:

• The figure shows the NHEJ pathway with labeled protein complexes:

  • KU → DNA-PKcs → Artemis → Polymerases → XRCC4–Ligase IV complex.

  • Each step connects recognition, end processing, and ligation.

Glossary:

• Ligase IV: Enzyme sealing DNA ends in NHEJ.

• XRCC4/XLF: Structural proteins stabilizing the ligation complex.

• DNA-PKcs: Kinase that activates repair enzymes via phosphorylation.

Key Takeaway:

Slide 25 – NHEJ: First Choice Mechanism for DSB Repair in Mammalian Cells

Key Concepts and Explanations:

• NHEJ is the dominant DSB repair pathway in mammalian cells because it operates throughout the entire cell cycle and does not require a homologous template.

Mechanistic Overview:

1. DNA End Recognition: Ku70–Ku80 binds and protects the DNA ends.

2. Synapsis Formation: DNA-PKcs joins both DNA ends together.

3. End Processing:

   • DNA ends are cleaned or filled by Artemis (endonuclease) and Pol μ / Pol λ (polymerases).

4. Ligation: Ligase IV–XRCC4–XLF complex seals the final nick.

Characteristics of NHEJ:

• Fast but error-prone: small insertions or deletions may occur at the repair site.

• Preferred for two-ended DSBs (e.g., caused by radiation).

• Critical for V(D)J recombination in immune cells (programmed DSBs).

Explanation of Visuals:

• Diagram illustrates stepwise progression:

  • Recognition → End bridging → Processing → Ligation.

• Key proteins are labeled at each step.

• Text emphasizes that NHEJ is the default repair pathway for most DSBs in mammalian cells.

Glossary:

• Synapsis: Temporary alignment of DNA ends before ligation.

• Error-prone repair: Repair process introducing small mutations.

• Two-ended DSB: Typical DSB with both strands broken near each other.

Key Takeaway:

Slide 26 – Cell Cycle Regulation of NHEJ and HR in Response to Ionizing Radiation (IR)

Key Concepts and Explanations:

• Cells regulate DSB repair based on the cell cycle phase to ensure the most appropriate repair mechanism is used:

1. NHEJ:

• Active in all phases (G1, S, G2, M).

• Dominates in G1 phase, when no sister chromatid is available.

• Repairs DSBs directly without needing a template.

2. HR (Homologous Recombination):

• Restricted to S and G2 phases, when a sister chromatid is present to serve as a repair template.

• Plays a major role in recovery from replication stress and radiation-induced DSBs.

Response to Ionizing Radiation (IR):

• IR induces both single-ended and two-ended DSBs.

  • Two-ended DSBs: handled mainly by NHEJ.

  • Single-ended DSBs (replication-associated): repaired by HR after replication fork collapse.

• Even in G2 phase, NHEJ remains the dominant repair route for two-ended DSBs.

Explanation of Visuals:

• Left: Cell-cycle diagram showing phases (G1–S–G2–M) with repair pathway activity:

  • Red zone (G1): NHEJ active.

  • Blue zone (S/G2): HR active.

• Right: Illustrations show the difference between base damage, replication fork collapse, and two-ended DSBs.

Glossary:

• Sister chromatid: Identical DNA copy produced during replication, used as HR template.

• Ionizing radiation: High-energy radiation that produces both single- and double-strand DNA breaks.

• Replication fork collapse: Stalling of DNA synthesis that results in a single-ended DSB.

Key Takeaway:

Slide 27 – Cell Cycle Regulation of NHEJ and HR in Response to Ionizing Radiation (IR)

Key Concepts and Explanations:

• The choice between NHEJ and HR depends on the cell cycle phase and the nature of the DSB.

• Ionizing radiation (IR) induces both:

  • Two-ended DSBs, typically repaired by NHEJ.

  • Single-ended DSBs (arising from collapsed replication forks), repaired by HR.

Mechanistic Overview:

1. In G1 phase:

   • No sister chromatid is available → NHEJ is the primary repair pathway.

2. In S/G2 phase:

   • HR becomes active due to the presence of a homologous template.

   • Repair is slower and requires many factors (BRCA1, RAD51, etc.) for homology search.

3. Subpathways of HR:

   • SDSA (Synthesis-Dependent Strand Annealing) — error-free, no crossover.

   • DSBR (Double-Strand Break Repair) — can result in crossovers (used in meiosis).

Explanation of Visuals:

• Flowchart shows IR-induced DSBs leading to different outcomes:

  • Two-ended breaks → NHEJ.

  • Single-ended breaks → HR (via SSA, SDSA, DSBR).

• HR pathway requires many cofactors and is slower but highly accurate.

Glossary:

• SDSA: HR subpathway without crossing over.

• SSA: Single-Strand Annealing, a less accurate HR-related pathway.

• DSBR: Classical homologous recombination pathway forming Holliday junctions.

Key Takeaway:

Slide 28 – Regulation of RAD51-Mediated Recombination

Key Concepts and Explanations:

• RAD51 is the central recombinase driving the strand invasion step of homologous recombination (HR).

• Its activity is tightly regulated to ensure HR occurs only at the right time and place.

Mechanistic Overview:

1. Initiation (DNA-end resection):

   • MRN complex and CtIP process DSB ends to generate 3′ single-stranded DNA (ssDNA) overhangs.

   • These ssDNA regions are first coated by RPA (Replication Protein A) to prevent secondary structures.

2. RAD51 Loading:

   • BRCA1 and BRCA2 coordinate the replacement of RPA with RAD51, forming a nucleoprotein filament.

   • RAD51 filament searches for and invades the homologous DNA sequence on the sister chromatid.

3. Homology Search and Strand Exchange:

   • RAD51-mediated invasion forms a D-loop (displacement loop), enabling DNA synthesis using the intact strand as a template.

Explanation of Visuals:

• Diagram shows sequential recruitment:
  DSB → MRN/CtIP → RPA binding → RAD51 filament formation → D-loop → HR resolution.

• Right-side graph highlights key regulators (BRCA1/2, PALB2, RAD52) and cofactors required for filament stabilization.

Glossary:

• RPA: Protein that binds ssDNA and prevents degradation.

• D-loop: Structure formed when ssDNA invades homologous duplex DNA.

• BRCA2: Facilitates RAD51 loading onto ssDNA.

Key Takeaway:

Slide 29 – DNA-End Resection Governs DSB Repair Pathway Choice

Key Concepts and Explanations:

• The extent of DNA-end resection (trimming of DSB ends) determines whether the cell uses NHEJ or HR.

Mechanistic Comparison:

• NHEJ:

  • Requires no or minimal end resection.

  • DNA ends remain blunt or slightly processed, immediately ligated by Ligase IV.

  • Promoted by 53BP1, which protects DNA ends from excessive resection.

• HR:

  • Requires extensive 5′–3′ end resection to generate ssDNA overhangs for RAD51 loading.

  • Promoted by BRCA1, CtIP, and the MRN complex.

  • Incompatible with Ku binding.

Regulatory Balance:

• 53BP1 and BRCA1 act antagonistically to control pathway choice:

  • 53BP1 favors NHEJ (DNA protection).

  • BRCA1 favors HR (DNA processing and resection).

Explanation of Visuals:

• Diagram shows the DSB “decision point”:

  • Top branch: NHEJ pathway (Ku and 53BP1 block resection).

  • Bottom branch: HR pathway (BRCA1, CtIP promote resection and RAD51 assembly).

• Resection extent determines which repair pathway proceeds.

Glossary:

• DNA-end resection: Controlled degradation of 5′ DNA ends to expose 3′ ssDNA for HR.

• CtIP: Endonuclease cooperating with MRN in resection initiation.

• 53BP1: NHEJ-promoting protein preventing HR by blocking end resection.

Key Takeaway:

Slide 30 – Antagonistic Relationship Between 53BP1 and BRCA1 During DSB Repair Pathway Choice

Key Concepts and Explanations:

• 53BP1 and BRCA1 are opposing regulators of DSB repair:

  • 53BP1 protects DNA ends, promoting NHEJ.

  • BRCA1 promotes DNA-end resection, favoring HR.

• Their competition determines the cell’s repair strategy — a critical factor in tumorigenesis and therapy response.

Mechanistic Insight:

1. In BRCA1-deficient cells, 53BP1 dominates:

   • Resection is blocked → DSBs repaired by error-prone NHEJ.

   • Leads to chromosomal fusions and genomic instability.

   • Increases cancer risk (e.g., BRCA1-related breast cancers).

2. Loss of 53BP1 in BRCA1-deficient cells restores partial HR ability:

   • Reduces chromosomal abnormalities.

   • Rescues DNA repair and decreases tumor formation.

Experimental Evidence:

• BRCA1-deficient mouse models with 53BP1 deletion show:

  • Fewer radial chromosome structures (a sign of misrepair).

  • Lower incidence of mammary tumors.

  • Improved genome stability.

Explanation of Visuals:

• Left graph: Mammary tumor incidence in wild-type, BRCA1-null, and BRCA1/53BP1-double mutants — deletion of 53BP1 reduces tumorigenesis.

• Right diagrams: Illustrate how 53BP1 suppresses resection (favoring NHEJ) vs. BRCA1 promoting HR via resection.

Glossary:

• Radial chromosomes: Abnormal chromosome fusions from misrepaired DSBs.

• 53BP1 knockout: Experimental deletion of the 53BP1 gene to test pathway balance.

• Genomic instability: Accumulation of chromosomal rearrangements and mutations.

Key Takeaway:

Slide 31 – Antagonistic Relationship Between 53BP1 and BRCA1 During DSB Repair Pathway Choice (Detailed Overview)

Key Concepts and Explanations:

• This slide further explores how 53BP1 and BRCA1 dynamically determine whether a cell uses HR or NHEJ to repair double-strand breaks (DSBs).

• Their interaction is a molecular switch:

  • BRCA1 promotes HR by stimulating DNA-end resection.

  • 53BP1 promotes NHEJ by blocking resection and protecting DNA ends.

Mechanistic Scenarios:

1. BRCA1⁺ / 53BP1⁺ (normal situation):

   • Balanced system — both proteins compete.

   • If BRCA1 wins → HR (accurate repair).

   • If 53BP1 dominates → NHEJ (quick, error-prone repair).

2. BRCA1⁻ / 53BP1⁺ (BRCA1-deficient):

   • Resection is blocked → only NHEJ available.

   • Results in error-prone repair, chromosomal fusions, and genome instability.

   • Leads to cancer predisposition (e.g., BRCA1-deficient tumors).

3. BRCA1⁻ / 53BP1⁻ (double knockout):

   • Resection partially restored → limited HR can occur again.

   • Genome stability improves and tumor risk decreases (shown in mouse models).

Experimental Evidence:

• Cells lacking BRCA1 but also missing 53BP1 regain partial HR repair capacity.

• These findings explain why 53BP1 loss can rescue BRCA1-deficiency phenotypes.

Explanation of Visuals:

• Left: Diagram shows different combinations of BRCA1 and 53BP1 expression and their effects on pathway choice.

• Right: Table summarizing repair outcomes — “Accurate HR” vs “Error-prone NHEJ” — depending on which regulator dominates.

Glossary:

• Resection: Controlled trimming of 5′ ends to expose 3′ single-stranded DNA for HR.

• Chromosomal fusions: Aberrant joining of non-homologous chromosomes due to misrepaired DSBs.

• Double knockout (DKO): Genetic deletion of two genes to study their combined effect.

Key Takeaway:

Slide 32 – Antagonistic Relationship Between 53BP1 and BRCA1 (Key Mechanistic Summary and Review Questions)

Key Concepts and Explanations:

• This slide summarizes the mechanistic interplay between BRCA1 and 53BP1 and links it to therapeutic concepts like synthetic lethality (e.g., PARP inhibitors).

• It also provides review questions to test understanding of pathway choice and regulatory balance.

Mechanistic Summary:

• 53BP1 and its cofactors (RIF1, Shieldin complex) block DNA-end resection, enforcing NHEJ.

• BRCA1 counters this by recruiting CtIP and MRN complex, initiating resection and promoting HR.

• The dominant protein determines which pathway the cell uses:

  • 53BP1 dominant → NHEJ

  • BRCA1 dominant → HR

Therapeutic Relevance:

• In BRCA1-mutant tumors:

  • HR is defective → cells rely solely on NHEJ or alternative repair.

  • PARP inhibitors (e.g., Olaparib) exploit this weakness via synthetic lethality.

• If 53BP1 is lost in BRCA1-mutant tumors:

  • Partial HR restoration → PARP inhibitors become less effective (therapy resistance).

Key Questions Addressed on the Slide:

1. Why is RAD51 activity lost in BRCA1-deficient cells?
   Because BRCA1 (and BRCA2) are required for RAD51 filament loading onto resected DNA.

2. Why only one repair pathway at a time?
   Because NHEJ and HR are mutually exclusive — resection commitment blocks NHEJ and vice versa.

3. What happens in synthetic lethality (BRCA1 + PARP inhibition)?
   Both HR and SSB repair are blocked → lethal accumulation of DSBs.

4. How do 53BP1 and BRCA1 influence treatment outcomes?

   • 53BP1 promotes NHEJ and PARP sensitivity.

   • Loss of 53BP1 restores HR and causes PARP resistance.

Explanation of Visuals:

• Top diagrams show BRCA1 vs. 53BP1 dominance determining HR or NHEJ.

• Bottom schematic summarizes experimental outcomes and drug response relationships.

Glossary:

• Shieldin complex: Downstream effector of 53BP1 that physically blocks resection.

• Synthetic lethality: Combined loss of two repair pathways (e.g., BRCA1 + PARP inhibition) leads to cell death.

• PARP inhibitors: Drugs targeting single-strand break repair, lethal to HR-deficient cells.

Key Takeaway: